RT @medical_xpress: Why focusing on #COVID deaths undercounts the health harms of the #pandemic: New research @ConversationEDU https://t.co…
RT @medical_xpress: Why focusing on #COVID deaths undercounts the health harms of the #pandemic: New research @ConversationEDU https://t.co…
RT @medical_xpress: Why focusing on #COVID deaths undercounts the health harms of the #pandemic: New research @ConversationEDU https://t.co…
RT @medical_xpress: Why focusing on #COVID deaths undercounts the health harms of the #pandemic: New research @ConversationEDU https://t.co…
RT @medical_xpress: Why focusing on #COVID deaths undercounts the health harms of the #pandemic: New research @ConversationEDU https://t.co…
RT @medical_xpress: Why focusing on #COVID deaths undercounts the health harms of the #pandemic: New research @ConversationEDU https://t.co…
RT @medical_xpress: Why focusing on #COVID deaths undercounts the health harms of the #pandemic: New research @ConversationEDU https://t.co…
Why focusing on #COVID deaths undercounts the health harms of the #pandemic: New research @ConversationEDU https://t.co/MpqkWAwKyS https://t.co/hQfeSlUvnX
3/9 📏アウトカムは以下の通り ◎Primary:180日後に退院から経過していた日数 ※自宅、もしくは医療機関ではない宿泊施設への退院のみ ◯Secondary:180日死亡率、割り付けから28日までの非挿管/非ICU期間、180日目のEQ-5D-5L(リンク参照)、BADL、IADL、WHODAS 2.0など https://t.co/BENTshHzIT
RT @aj_lloyduk: EQ-5D-5L development paper reaches 3000 citations. https://t.co/4MU3Vl8PuT @EuroQol #eq5d #euroqol
EQ-5D-5L development paper reaches 3000 citations. https://t.co/4MU3Vl8PuT @EuroQol #eq5d #euroqol
Paper describing the development of EQ-5D-5L hits 2500 citations. Well done Mike Herdman, colleagues and @EuroQol https://t.co/4MU3Vlqqmr #eq5d
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
RT @Gae_Gallo: #OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it?…
#OpenSourceResearch Week4 #SoMe4Surgery #colorectalsurgery PROMs The EQ-5D-5L has two components Have you ever used it? @escp_tweets @YouSICCR @me4_so https://t.co/IRarAWmCfQ https://t.co/yVNeMHM7DE
#Top10 Development, refinement, and testing of #valuesets remains a core topic. For example for the (then) new version of the #EQ5D five-level version: https://t.co/kiB9yaKTgR #healtheconomics #utilities #openaccess